medicare and glp-1 The Bridge Begins July 1, 2026: What Our Patients Need to Know Medicare Expands GLP-1 Medication Access

Think of your body like a smart system of checks and balances

Consistency may matter more than timing itself, especially when supplementation is used for general energy support or longevity-focused routines

Key Signs and Symptoms of EDS Flexible, fragile, or easily bruised skin Recurrent injuries, sprains, or dislocations Poor wound healing / scarring Chronic musculoskeletal pain GI issues such as gastroparesis or IBS Autonomic dysfunction (POTS, dizziness, tachycardia) Fatigue, exercise intolerance Temperature sensitivity Migraines, headaches, neuropathic pain Hypermobile EDS (hEDS) is the most common subtypeand also the most misdiagnosed and misunderstood

Theres no outrunning the GLP-1 wave Given the ongoing wave of media coverage, a class of drugs known as GLP-1 agonists is becoming increasingly well-known

No redness

This indicates that these two components entered the rat body quickly, and CI had no effect on its pharmacokinetic parameters ( Earlier studies have indicated that TCA concentration in serum, liver, kidney, and brain tissue of rats was determined following a single-dose intragastric administration of TCA